LENZ Therapeutics's total assets for Q3 2025 were $210.70M, a decrease of -3.05% from the previous quarter. LENZ total liabilities were $16.78M for the fiscal quarter, a 52.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.